Nuveen Asset Management, LLC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$164,447
-27.6%
95,0560.0%0.00%
Q1 2024$227,184
-91.0%
95,056
-87.5%
0.00%
-100.0%
Q4 2023$2,535,192
-30.9%
761,319
-22.4%
0.00%0.0%
Q3 2023$3,667,911
+207.0%
980,725
+250.5%
0.00%
Q2 2023$1,194,857
+99305.7%
279,826
+59.3%
0.00%
Q1 2023$1,202
-67.2%
175,659
-62.0%
0.00%
-100.0%
Q4 2022$3,664
-99.9%
462,526
-36.6%
0.00%
-66.7%
Q3 2022$7,010,000
+9.1%
729,437
-17.8%
0.00%
+50.0%
Q2 2022$6,426,000
-48.7%
887,585
-13.8%
0.00%
-50.0%
Q1 2022$12,520,000
+11.1%
1,029,606
+45.8%
0.00%
+33.3%
Q4 2021$11,271,000
-3.1%
706,198
-2.5%
0.00%
-25.0%
Q3 2021$11,633,000
+10.6%
723,943
-4.8%
0.00%
+33.3%
Q2 2021$10,520,000
+6.4%
760,731
+12.4%
0.00%0.0%
Q1 2021$9,888,000
-13.9%
676,791
+2.4%
0.00%
-25.0%
Q4 2020$11,484,000
-45.1%
660,806
-42.0%
0.00%
-50.0%
Q3 2020$20,905,000
+2.4%
1,139,871
-0.3%
0.01%0.0%
Q2 2020$20,412,000
+1.2%
1,142,875
-8.1%
0.01%
-20.0%
Q1 2020$20,175,000
-42.3%
1,243,836
-35.9%
0.01%
-23.1%
Q4 2019$34,961,000
-5.7%
1,941,700
+6.1%
0.01%
-13.3%
Q3 2019$37,074,000
+44.3%
1,829,915
+57.4%
0.02%
+50.0%
Q2 2019$25,695,0001,162,6910.01%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,100,000$1,903,0001.75%
AlphaCentric Advisors LLC 1,000,000$1,730,0001.27%
Tejara Capital Ltd 1,030,386$1,782,5680.65%
Rubric Capital Management LP 10,400,000$17,992,0000.47%
Birchview Capital, LP 270,000$467,1000.43%
TANG CAPITAL MANAGEMENT LLC 1,050,000$1,816,5000.18%
Bridge City Capital, LLC 316,009$546,6960.18%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$5,252,4130.16%
Tyche Wealth Partners LLC 215,902$373,5100.09%
Pennant Investors, LP 168,100$290,8130.08%
View complete list of COHERUS BIOSCIENCES INC shareholders